Page last updated: 2024-11-11

heme d1

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

heme d1: extractable heme from Pseudomonas nitrite reductase [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

ferroheme d1 : A ferroheme having four carboxy groups and oxo groups on two of the pyrrole rings. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID53356663
CHEBI ID61147
MeSH IDM0093766

Synonyms (7)

Synonym
[(2e)-3-[(7r,12r)-18-(2-carboxyethyl)-7,12-bis(carboxymethyl)-3,7,12,17-tetramethyl-8,13-dioxo-7,8,12,13-tetrahydroporphyrin-2-yl-kappa(4)n(21),n(22),n(23),n(24)]prop-2-enoato(2-)]iron
haem d1
CHEBI:61147
ferroheme d1
{3-[18-(2-carboxyethyl)-7,12-bis(carboxymethyl)-3,7,12,17-tetramethyl-8,13-dioxo-7,8,12,13-tetrahydroporphyrin-2-yl--kappa(4)n(21),n(22),n(23),n(24)]acrylato(2-)}iron
dioneheme
heme d1
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (35)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (20.00)18.7374
1990's9 (25.71)18.2507
2000's3 (8.57)29.6817
2010's13 (37.14)24.3611
2020's3 (8.57)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.86%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other34 (97.14%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]